Scienture (SCNX) Stock: Buy, Sell, or Hold?
SCNX - Scienture Holdings, Inc. Common Stock
$2.88
0.11 (3.97%)
▲
5d:
-14.29%
30d:
+903.48%
90d:
+684.53%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 11, 2026
17d
Get Alerted When SCNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SCNX is down 14.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: SCNX is down 14.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SCNX is currently trading at $2.88, which is considered slightly high relative to its 30-day fair value range of $0.30 to $3.48.
Technical Outlook: Technically, SCNX is in a uptrend. Immediate support is located at $2.64, while resistance sits at $3.93. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: SCNX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $37.50 (+1202.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SCNX is in a uptrend. Immediate support is located at $2.64, while resistance sits at $3.93. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: SCNX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $37.50 (+1202.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.30 -
$3.48
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.0%)
- BULLISH: Trading 1202.1% below Wall St target ($37.50)
- WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.30 -
$3.48
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.64
Resistance Level
$3.93
Current Trend
Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
21.83
Wall Street Target
$37.50
(+1202.1%)
Revenue Growth (YoY)
449.1%
Share & Embed Analysis
Last updated: October 24, 2026 2:29 AM ET
Data refreshes hourly during market hours. Next update: 3:29 AM
Data refreshes hourly during market hours. Next update: 3:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SCNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Pharmaceutical Retailers Stocks
Top-rated stocks in Pharmaceutical Retailers by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HITI
High Tide Inc |
STRONG BUY
7 analysts |
$5 | 62 BUY |
